ArticlePloS one2014

CTNNB1 S45F mutation predicts poor efficacy of meloxicam treatment for desmoid tumors: a pilot study.

Shunsuke Hamada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.